Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Historical Holders from Q1 2021 to Q3 2025

Type / Class
Equity / Ordinary Shares / American Depositary Shares
Symbol
CMMB on Nasdaq
Shares outstanding
384,317,619
Price per share
$0.89
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
0
Total reported value
$0
Share change
-4,216,888
Value change
-$4,891,583
Avg sell value change
-0%
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MORGAN STANLEY 3.2% $16,120,177 13,213,260 Morgan Stanley 31 Jul 2025
OrbiMed Israel BioFund GP Limited Partnership 4.8% $1,183,165 969,807 ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP 18 Jun 2025
SPHERA FUNDS MANAGEMENT LTD. 4.8% $963,458 900,428 Sphera Funds Management Ltd. 31 Mar 2025
As of 30 Sep 2025, Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 0 institutional shareholders filing 13F forms. They reported no common stock holdings, but disclosed options positions.

Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 0 $0 -$4,891,583 0
2025 Q2 4,230,788 $4,907,708 +$580,032 $1.16 14
2025 Q1 3,731,679 $4,067,948 -$471,792 $1.09 17
2024 Q4 4,160,723 $7,530,756 -$700,297 $1.81 16
2024 Q3 4,549,767 $7,142,810 +$3,023,403 $1.57 15
2024 Q2 2,672,756 $2,441,306 +$15,799 $0.9125 15
2024 Q1 2,661,598 $2,073,381 -$36,319 $0.7790 14
2023 Q4 2,813,782 $1,434,861 +$107,627 $0.5100 16
2023 Q3 2,530,576 $2,264,861 -$524 $0.8950 11
2023 Q2 2,531,115 $3,327,272 -$562,172 $1.32 10
2023 Q1 2,889,758 $4,560,246 -$695,559 $1.59 12
2022 Q4 3,313,486 $10,603,060 +$239,615 $3.20 13
2022 Q3 3,249,704 $8,092,000 -$130,381 $2.49 13
2022 Q2 3,288,318 $12,166,000 -$117,042 $3.70 13
2022 Q1 3,307,352 $15,879,000 -$113,857 $4.80 14
2021 Q4 3,288,041 $22,686,000 +$310,556 $6.90 14
2021 Q3 3,241,493 $35,915,000 +$733,099 $11.08 13
2021 Q2 3,085,723 $58,690,000 +$1,761,093 $19.02 11
2021 Q1 2,876,992 $82,600,000 +$82,600,119 $28.74 10